The primary objective of our centre is to translate recent huge advances in the basic understanding of the pathogenesis of coeliac disease to the clinic – to improve disease diagnostics, to implement novel treatments and to identify new therapeutic targets for this common disease.
The secondary objective is to become a clinical research site at the international forefront which will provide optimal patient care and which will be a unique training site for basic scientists and clinicians.
Recruitment of coeliac patients to a clinical study starting up after the summer
June 21, 2017 4:22 PM
Coeliac patients from the Oslo area are invited to participate in a study of how the immune defense reacts to a gluten challenge. The goal of the study is to investigate how the immune system reacts to a gluten challenge, measured by the time points different immune cells appear in the blood.
Online chat with Coeliac UK
June 21, 2017 4:12 PM
Professors Knut Lundin and Ludvig Sollid answered questions in a Facebook live chat arranged by Coeliac UK, Friday June 9'th.
- High-Throughput Single-Cell Analysis of B Cell Receptor Usage among Autoantigen-Specific Plasma Cells in Celiac Disease June 11, 2017 11:00 AM
- Similar Responses of Intestinal T-cells From Untreated Children and Adults With Celiac Disease to Deamidated Gluten Epitopes May 26, 2017 11:00 AM
- Epitope-specific immunotherapy targeting CD4-positive T cells in coeliac disease: two randomised, double-blind, placebo-controlled phase 1 studies May 17, 2017 11:00 AM